Effect of Blueberry Consumption on Metabolic Syndrome & DNA Damage

NCT ID: NCT02075307

Last Updated: 2020-12-23

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

7 participants

Study Classification

INTERVENTIONAL

Study Start Date

2014-01-31

Study Completion Date

2017-04-04

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Obesity usually brings with it disturbances in the body that increase the chances of developing serious diseases like diabetes and cancer. These disturbances include one or more symptoms of a condition called "metabolic syndrome" that often leads to diabetes. High levels of damage to the DNA that makes up our chromosomes have also been observed in obese people. It is possible that these two disturbances are connected. The goal of this project is to test this whether consumption of blueberries will improve these abnormalities.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Unbalanced diets rich in refined carbohydrate calories, saturated fats, and trans fats, but low in vitamins, minerals, fiber, polyphenolics and ω-3 fatty acids are common in the United States, particularly among the obese. Insulin resistance and high levels of DNA damage commonly accompany obesity. There also appears to be a relationship between oxidative DNA-damage and biomarkers that characterize metabolic syndrome. The bioactivity of blueberries is usually attributed to their high content of polyphenolics which can reduce oxidative DNA damage. Since oxidative damage to mitochondrial DNA is a suggested causal factor leading to increased insulin resistance, we will test if blueberry consumption can be an ameliorative dietary factor for insulin resistance as well. If blueberry consumption both shifts metabolism away from insulin resistance and reduces DNA damage, it may be a useful tool to assist in understanding relationships between these two obesity-associated conditions.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Metabolic Syndrome Insulin Resistance DNA Damage

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

insulin diabetes obesity DNA damage metabolic syndrome

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Blueberry Powder

The intervention group will receive the Blueberry freeze-dried powder equivalent to 1 cup of whole Blueberries twice a day for 8 weeks (i.e. 2 cups/day).

Group Type EXPERIMENTAL

Blueberry Powder

Intervention Type DIETARY_SUPPLEMENT

Placebo Powder

The placebo group will receive placebo powder in the same amounts for the same duration.

Group Type PLACEBO_COMPARATOR

Placebo

Intervention Type DIETARY_SUPPLEMENT

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Blueberry Powder

Intervention Type DIETARY_SUPPLEMENT

Placebo

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Age 30-60 years;
2. BMI \> 30;
3. Blood pressure \<140/90 mmHg without antihypertensive medicines or with a stable dose of antihypertensive medicines (no change in last 3 months).;
4. Insulin resistance (HOMA/IR) \> 2.0;
5. Willing to restrict intake of high polyphenol-containing foods during the trial period;
6. Willing to forego intake of nutritional supplements other than a multivitamin;
7. Willing to maintain their current daily level of exercise throughout the study.

Exclusion Criteria

1. Known diabetes mellitus according to the 2013 ADA criteria;
2. Medications known to affect glucose metabolism;
3. Weight loss pharmacotherapy;
4. Lipid-lowering medication;
5. Untreated thyroid or chronic liver, renal, or cardiovascular disease;
6. Smoking;
7. Pregnancy- a negative urine pregnancy test will be documented for any women participants of childbearing age prior to enrollment.
8. History of allergic reactions to blueberries.
9. Any pathological condition known to alter white blood cell count over the previous 6 months;
10. Exposure to drugs known to cause mutations or radiation within the previous 6 months;
11. Alcohol consumption greater than 2 drinks/d for males and 1 drink/d for females.
Minimum Eligible Age

30 Years

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

U.S. Highbush Blueberry Council

OTHER

Sponsor Role collaborator

USDA Agricultural Research Station in Albany, CA

UNKNOWN

Sponsor Role collaborator

UCSF Benioff Children's Hospital Oakland

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Bruce Ames, PhD

Role: PRINCIPAL_INVESTIGATOR

Children's Hospital & Research Center at Oakland

Ashutosh Lal, MD

Role: PRINCIPAL_INVESTIGATOR

Children's Hospital & Research Center at Oakland

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Children's Hospital & Research Center Oakland

Oakland, California, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2012-033

Identifier Type: -

Identifier Source: org_study_id